Literature DB >> 17553901

Hawaii cohort study of serum micronutrient concentrations and clearance of incident oncogenic human papillomavirus infection of the cervix.

Marc T Goodman1, Yurii B Shvetsov, Katharine McDuffie, Lynne R Wilkens, Xuemei Zhu, Adrian A Franke, Cathy Cramer Bertram, Bruce Kessel, Marge Bernice, Christian Sunoo, Lily Ning, David Easa, Jeffrey Killeen, Lori Kamemoto, Brenda Y Hernandez.   

Abstract

The degree to which the resolution of human papillomavirus (HPV) infection parallels exposure to other factors, particularly those related to nutritional status, is a relatively unexplored area of research. We established a cohort of women for long-term follow-up to examine the association of serum retinol, carotenoid, and tocopherol concentrations with the clearance of incident cervical HPV infection. Interviews and biological specimens were obtained at baseline and at 4-month intervals. At each visit, a cervical cell specimen for HPV DNA analysis and cytology and a fasting blood sample to measure micronutrient levels were collected. A Cox proportional hazards model was used to study the relationship between clearance of 189 incident (type-specific) oncogenic HPV infections and the levels of 20 serum micronutrients among 122 women. Higher circulating levels of trans-zeaxanthin, total trans-lutein/zeaxanthin, cryptoxanthin (total and beta), total trans-lycopene and cis-lycopene, carotene (alpha, beta, and total), and total carotenoids were associated with a significant decrease in the clearance time of type-specific HPV infection, particularly during the early stages of infection (<or=120 days). HPV clearance time was also significantly shorter among women with the highest compared with the lowest serum levels of alpha-tocopherol and total-tocopherol, but significant trends in these associations were limited to infections lasting <or=120 days. Clearance of persistent HPV infection (lasting >120 days) was not significantly associated with circulating levels of carotenoids or tocopherols. Results from this investigation support an association of micronutrients with the rapid clearance of incident oncogenic HPV infection of the uterine cervix.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553901     DOI: 10.1158/0008-5472.CAN-07-0313

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Biomarkers of oxidant load and type-specific clearance of prevalent oncogenic human papillomavirus infection: markers of immune response?

Authors:  Erin M Siegel; Nitin Patel; Beibei Lu; Ji-Hyun Lee; Alan G Nyitray; Neal E Craft; Krystyna Frenkel; Luisa L Villa; Eduardo L Franco; Anna R Giuliano
Journal:  Int J Cancer       Date:  2011-11-28       Impact factor: 7.396

2.  Plasma micronutrients and the acquisition and clearance of anal human papillomavirus infection: the Hawaii HPV cohort study.

Authors:  Yurii B Shvetsov; Brenda Y Hernandez; Lynne R Wilkens; Pamela J Thompson; Adrian A Franke; Xuemei Zhu; Marc T Goodman
Journal:  Cancer Res       Date:  2010-10-08       Impact factor: 12.701

3.  Burden of invasive squamous cell carcinoma of the penis in the United States, 1998-2003.

Authors:  Brenda Y Hernandez; Jill Barnholtz-Sloan; Robert R German; Anna Giuliano; Marc T Goodman; Jessica B King; Serban Negoita; Jose M Villalon-Gomez
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

4.  Plasma carotenoids, tocopherols, retinol and breast cancer risk: results from the Shanghai Women Health Study (SWHS).

Authors:  Tsogzolmaa Dorjgochoo; Yu-Tang Gao; Wong-Ho Chow; Xiao-Ou Shu; Honglan Li; Gong Yang; Qiuyin Cai; Nathaniel Rothman; Hui Cai; Adrian A Franke; Wei Zheng; Qi Dai
Journal:  Breast Cancer Res Treat       Date:  2008-12-20       Impact factor: 4.872

5.  Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study.

Authors:  Marc T Goodman; Yurii B Shvetsov; Katharine McDuffie; Lynne R Wilkens; Xuemei Zhu; Pamela J Thompson; Lily Ning; Jeffrey Killeen; Lori Kamemoto; Brenda Y Hernandez
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

6.  Duration and clearance of anal human papillomavirus (HPV) infection among women: the Hawaii HPV cohort study.

Authors:  Yurii B Shvetsov; Brenda Y Hernandez; Katharine McDuffie; Lynne R Wilkens; Xuemei Zhu; Lily Ning; Jeffrey Killeen; Lori Kamemoto; Marc T Goodman
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

7.  Multiple high-risk HPV genotypes are grouped by type and are associated with viral load and risk factors.

Authors:  L Del Río-Ospina; S C Soto-DE León; M Camargo; R Sánchez; D A Moreno-Pérez; A Pérez-Prados; M E Patarroyo; M A Patarroyo
Journal:  Epidemiol Infect       Date:  2017-02-10       Impact factor: 4.434

8.  Tumour suppressor gene methylation and cervical cell folate concentration are determinants of high-risk human papillomavirus persistence: a nested case control study.

Authors:  Janet E Flatley; Alexandra Sargent; Henry C Kitchener; Jean M Russell; Hilary J Powers
Journal:  BMC Cancer       Date:  2014-11-03       Impact factor: 4.430

9.  Dietary Antioxidant Intake and Human Papillomavirus Infection: Evidence from a Cross-Sectional Study in Italy.

Authors:  Martina Barchitta; Andrea Maugeri; Claudia La Mastra; Maria Clara La Rosa; Giuliana Favara; Roberta Magnano San Lio; Antonella Agodi
Journal:  Nutrients       Date:  2020-05-12       Impact factor: 5.717

10.  Plasma processing conditions substantially influence circulating microRNA biomarker levels.

Authors:  Heather H Cheng; Hye Son Yi; Yeonju Kim; Evan M Kroh; Jason W Chien; Keith D Eaton; Marc T Goodman; Jonathan F Tait; Muneesh Tewari; Colin C Pritchard
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.